Haemonetics (HAE) Total Debt Growth (3y) (2013 - 2026)
Haemonetics (HAE) Total Debt Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | 24.63% |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn | 4.89% |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn | 11.72% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 0.11% |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | -0.47% |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | -1.01% |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | -13.48% |
| 10 | Haemonetics | 4.93 Bn | 4.70 Bn | 202.80 Mn | 15.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 15.97% |
| Mar 28, 2026 | 16.93% |
| Dec 27, 2025 | 25.88% |
| Sep 27, 2025 | 14.41% |
| Jun 28, 2025 | 16.73% |
| Mar 29, 2025 | 16.55% |
| Dec 28, 2024 | 16.37% |
| Sep 28, 2024 | 16.20% |
| Jun 29, 2024 | 15.98% |
| Mar 30, 2024 | 4.51% |
| Dec 30, 2023 | 41.12% |
| Sep 30, 2023 | 17.99% |
| Jul 1, 2023 | 13.13% |
| Apr 1, 2023 | 26.04% |
| Dec 31, 2022 | 27.30% |
| Oct 1, 2022 | 30.15% |
| Jul 2, 2022 | 20.90% |
| Apr 2, 2022 | 30.25% |
| Jan 1, 2022 | 31.24% |
| Oct 2, 2021 | 31.46% |